Mounjaro and the Pattern We Keep Ignoring

When I first started hearing about this latest miracle drug, I didn’t feel hope. I felt déjà vu.

Because we’ve been here before.

We’ve been here with miracle tablets, miracle injections, miracle technologies, miracle platforms. Every time, there’s a rush. Every time, there’s money. Every time, there’s a small group of people who get incredibly rich, incredibly fast, while millions of ordinary people effectively become the test subjects for whatever the latest “breakthrough” happens to be.

And years later, when the dust settles and the consequences start showing up, the people who made the billions have retired to their beachfront homes, and the public are left dealing with the fallout.

So when I hear the word Mounjaro, I don’t hear “medical advancement”.

I hear, “Here we go again.”

This isn’t about whether it works

This isn’t a medical debate.

This isn’t about whether it helps people with diabetes or manages weight loss.

This is about the pattern we’ve seen for decades, where massive corporations and investors effectively play Russian roulette with huge populations of people, knowing full well that if anything goes wrong, it will be years down the line, long after the money has been made.

And they will not be the ones paying the price.

Cast your mind back to 2020 and 2021

I don’t care what side of the fence you sit on.

What we all saw was speed. Enormous speed. Rollout at scale. Huge financial gains for pharmaceutical companies. And a public told, “Trust us.”

Now, years later, you hear more and more people saying it should have been slower. More cautious. More transparent. Less rushed.

But at the time, there was money to be made. And money was made. An absolute fortune.

2020 created a wave of new millionaires and billionaires while the rest of the world sat at home, worried, confused, and largely powerless.

That memory is still fresh.

So forgive people for not instantly clapping when the next miracle injection appears.

Go back even further

The internet.

Social media.

Smartphones.

Every one of these arrived with excitement and opportunity. And every one of them now comes with a very visible trail of psychological, social and cultural damage that nobody seemed too bothered about while the money was rolling in.

You can almost hear the boardroom conversations that must have happened.

“Could this be bad for mental health?”

“Yes, possibly.”

“Can we make billions?”

“Yes.”

“Right then.”

The investors are never questioned

This is the bit nobody talks about.

The investors who throw millions and billions into these industries are never the ones stood in front of cameras being asked about ethics, morals, long-term consequences, or what they knowingly ignored in order to turn a profit.

They hide behind balance sheets.

They aren’t the ones whose names are attached when problems surface. They’ve already made their returns and moved on.

So when the next miracle product appears, you have to ask: Who’s getting rich from this?

Because history tells us that question matters far more than “is this good for people?”

Miracle drugs have a long, ugly history

We’ve seen miracle cures before.

We’ve seen drugs rushed to market.

We’ve seen tablets, injections and treatments hailed as breakthroughs, only for victims to appear years later when the side effects, dependencies or complications start showing up.

Thalidomide. Oxycontin. Vioxx.

I was born in 1963. I’m one of the lucky ones. In the years around my birth, thousands of babies were born with severe birth defects because thalidomide was being marketed as a safe treatment for morning sickness during pregnancy. Mothers were told it was perfectly safe.

It wasn’t.

Many people have forgotten that era.

But there are thousands of people in this world who don’t have the luxury of forgetting. They live every day with the physical consequences of a “miracle drug” that was rushed to market because there was money to be made.

And by then, it’s too late.

The money’s been made.

The accountability has evaporated.

And the people left dealing with it are the very same public who were told at the start, “This is amazing.”

So when I hear “Mounjaro”…

I don’t think innovation.

I think pattern.

I think about how many times society has been told, “This is safe, this is brilliant, this is the future,” only to find out later that the future came with a receipt nobody warned us about.

I think about how quickly something can be scaled when there’s profit involved, and how slowly caution moves when caution doesn’t generate revenue.

And I think, once again, millions of people are about to line up for the latest round of Russian roulette while a small elite group quietly count the money in the background.

Here we go again.

A Few Questions about Mounjaro